Roche Holding reported 25.35B in Debt for its second fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Alcon AG ALC:SW USD 5.07B 735M
Amgen AMGN:US USD 38.94B 241M
AstraZeneca AZN:LN USD 29.23B 67M
Bayer BAYN:GR EUR 41.65B 3.14B
Biogen BIIB:US USD 6.28B 1.8M
Bristol Myers Squibb BMY:US USD 39.32B 222M
Fresenius FRE:GR EUR 34.36B 5.75B
Galapagos GLPG:NA EUR 21.9M 784K
Genmab GEN:DC DKK 597M 32M
GlaxoSmithKline GSK:LN GBP 20.99B 1.13B
Hikma Pharmaceutical HIK:LN USD 1.28B 268M
Lonza Group LONN:SW CHF 2.23B 171M
Merck MRK:GR EUR 10.4B 622M
Novartis NOVN:VX USD 27.91B 530M
Orion ORNBV:FH EUR 214M 1000K
Recordati REC:IM EUR 1.7B 127.57M
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Roche Holding ROG:VX 25.35B 2.4B